The finding that syndecan-1 shed from the surface of tumor cells is another important mediator of osteoclastogenesis identifies the heparanase–syndecan-1–cytokine axis as a novel target for inhibiting osteoclastogenesis and ultimately for preventing the consequences of bone metastases. The gene discussed is HPSE; the disease is neoplasm.